Literature DB >> 23149553

Early brain injury alters the blood-brain barrier phenotype in parallel with β-amyloid and cognitive changes in adulthood.

Viorela Pop1, Dane W Sorensen, Joel E Kamper, David O Ajao, M Paul Murphy, Elizabeth Head, Richard E Hartman, Jérôme Badaut.   

Abstract

Clinical studies suggest that traumatic brain injury (TBI) hastens cognitive decline and development of neuropathology resembling brain aging. Blood-brain barrier (BBB) disruption following TBI may contribute to the aging process by deregulating substance exchange between the brain and blood. We evaluated the effect of juvenile TBI (jTBI) on these processes by examining long-term alterations of BBB proteins, β-amyloid (Aβ) neuropathology, and cognitive changes. A controlled cortical impact was delivered to the parietal cortex of male rats at postnatal day 17, with behavioral studies and brain tissue evaluation at 60 days post-injury (dpi). Immunoglobulin G extravasation was unchanged, and jTBI animals had higher levels of tight-junction protein claudin 5 versus shams, suggesting the absence of BBB disruption. However, decreased P-glycoprotein (P-gp) on cortical blood vessels indicates modifications of BBB properties. In parallel, we observed higher levels of endogenous rodent Aβ in several brain regions of the jTBI group versus shams. In addition at 60 dpi, jTBI animals displayed systematic search strategies rather than relying on spatial memory during the water maze. Together, these alterations to the BBB phenotype after jTBI may contribute to the accumulation of toxic products, which in turn may induce cognitive differences and ultimately accelerate brain aging.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23149553      PMCID: PMC3564189          DOI: 10.1038/jcbfm.2012.154

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  37 in total

1.  Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old.

Authors:  John L Robinson; Felix Geser; Maria M Corrada; Daniel J Berlau; Steven E Arnold; Virginia M-Y Lee; Claudia H Kawas; John Q Trojanowski
Journal:  Brain       Date:  2011-11-26       Impact factor: 13.501

2.  Aβ aggregation profiles and shifts in APP processing favor amyloidogenesis in canines.

Authors:  Viorela Pop; Elizabeth Head; Nicole C Berchtold; Charles G Glabe; Christa M Studzinski; Adam M Weidner; M Paul Murphy; Carl W Cotman
Journal:  Neurobiol Aging       Date:  2010-04-30       Impact factor: 4.673

Review 3.  Molecular and physiological responses to juvenile traumatic brain injury: focus on growth and metabolism.

Authors:  Talin Babikian; Mayumi L Prins; Yan Cai; Garni Barkhoudarian; Ivet Hartonian; David A Hovda; Christopher C Giza
Journal:  Dev Neurosci       Date:  2010-11-12       Impact factor: 2.984

4.  Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injury.

Authors:  David L Brody; David M Holtzman
Journal:  Exp Neurol       Date:  2005-11-23       Impact factor: 5.330

5.  Prevalence of long-term disability from traumatic brain injury in the civilian population of the United States, 2005.

Authors:  Eduard Zaloshnja; Ted Miller; Jean A Langlois; Anbesaw W Selassie
Journal:  J Head Trauma Rehabil       Date:  2008 Nov-Dec       Impact factor: 2.710

6.  Cerebral amyloid angiopathy, blood-brain barrier disruption and amyloid accumulation in SAMP8 mice.

Authors:  Jaume del Valle; Joaquim Duran-Vilaregut; Gemma Manich; Mercè Pallàs; Antoni Camins; Jordi Vilaplana; Carme Pelegrí
Journal:  Neurodegener Dis       Date:  2011-03-16       Impact factor: 2.977

Review 7.  Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier.

Authors:  David S Miller
Journal:  Trends Pharmacol Sci       Date:  2010-04-24       Impact factor: 14.819

8.  T lymphocytes impair P-glycoprotein function during neuroinflammation.

Authors:  Gijs Kooij; Jack van Horssen; Elizabeth C M de Lange; Arie Reijerkerk; Susanne M A van der Pol; Bert van Het Hof; Joost Drexhage; Anke Vennegoor; Joep Killestein; George Scheffer; Ruud Oerlemans; Rik Scheper; Paul van der Valk; Christine D Dijkstra; Helga E de Vries
Journal:  J Autoimmun       Date:  2009-12-02       Impact factor: 7.094

9.  Ascorbic acid prevents blood-brain barrier disruption and sensory deficit caused by sustained compression of primary somatosensory cortex.

Authors:  Jia-Li Lin; Yung-Hsin Huang; Yi-Ching Shen; Hsuan-Chi Huang; Pei-Hsin Liu
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-06       Impact factor: 6.200

10.  Detecting subtle changes in visuospatial executive function and learning in the amnestic variant of mild cognitive impairment.

Authors:  Kathryn V Papp; Peter J Snyder; Paul Maruff; Jennifer Bartkowiak; Robert H Pietrzak
Journal:  PLoS One       Date:  2011-07-14       Impact factor: 3.240

View more
  35 in total

1.  Perlecan domain V inhibits amyloid-β induced brain endothelial cell toxicity and restores angiogenic function.

Authors:  Christi Parham; Lisa Auckland; Jessica Rachwal; Douglas Clarke; Gregory Bix
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 2.  The Glymphatic System: A Beginner's Guide.

Authors:  Nadia Aalling Jessen; Anne Sofie Finmann Munk; Iben Lundgaard; Maiken Nedergaard
Journal:  Neurochem Res       Date:  2015-05-07       Impact factor: 3.996

3.  Crocus sativus Extract Tightens the Blood-Brain Barrier, Reduces Amyloid β Load and Related Toxicity in 5XFAD Mice.

Authors:  Yazan S Batarseh; Sonali S Bharate; Vikas Kumar; Ajay Kumar; Ram A Vishwakarma; Sandip B Bharate; Amal Kaddoumi
Journal:  ACS Chem Neurosci       Date:  2017-05-15       Impact factor: 4.418

4.  Longitudinal association between phosphatidylcholines, neuroimaging measures of Alzheimer's disease pathophysiology, and cognition in the Mayo Clinic Study of Aging.

Authors:  Danni Li; Clinton Hagen; Ashely R Fett; Hai H Bui; David Knopman; Prashanthi Vemuri; Mary M Machulda; Clifford R Jack; Ronald C Petersen; Michelle M Mielke
Journal:  Neurobiol Aging       Date:  2019-03-18       Impact factor: 4.673

5.  Expression of ATP-Binding Cassette Transporters B1 and C1 after Severe Traumatic Brain Injury in Humans.

Authors:  F Anthony Willyerd; Philip E Empey; Ashley Philbrick; Milos D Ikonomovic; Ava M Puccio; Patrick M Kochanek; David O Okonkwo; Robert S B Clark
Journal:  J Neurotrauma       Date:  2015-06-17       Impact factor: 5.269

6.  Vascular neural network phenotypic transformation after traumatic injury: potential role in long-term sequelae.

Authors:  J Badaut; G J Bix
Journal:  Transl Stroke Res       Date:  2013-11-29       Impact factor: 6.829

Review 7.  Early to Long-Term Alterations of CNS Barriers After Traumatic Brain Injury: Considerations for Drug Development.

Authors:  Beatriz Rodriguez-Grande; Aleksandra Ichkova; Sighild Lemarchant; Jerome Badaut
Journal:  AAPS J       Date:  2017-09-13       Impact factor: 4.009

8.  Enhanced penetration of exogenous EPCs into brains of APP/PS1 transgenic mice.

Authors:  Xiaoyang Yuan; Bin Mei; Le Zhang; Cuntai Zhang; Miao Zheng; Huifang Liang; Wei Wang; Jie Zheng; Ling Ding; Kai Zheng
Journal:  Am J Transl Res       Date:  2016-03-15       Impact factor: 4.060

9.  Water Exchange across the Blood-Brain Barrier in Obstructive Sleep Apnea: An MRI Diffusion-Weighted Pseudo-Continuous Arterial Spin Labeling Study.

Authors:  Jose A Palomares; Sudhakar Tummala; Danny J J Wang; Bumhee Park; Mary A Woo; Daniel W Kang; Keith S St Lawrence; Ronald M Harper; Rajesh Kumar
Journal:  J Neuroimaging       Date:  2015-08-29       Impact factor: 2.486

10.  Juvenile traumatic brain injury induces long-term perivascular matrix changes alongside amyloid-beta accumulation.

Authors:  Amandine Jullienne; Jill M Roberts; Viorela Pop; M Paul Murphy; Elizabeth Head; Gregory J Bix; Jérôme Badaut
Journal:  J Cereb Blood Flow Metab       Date:  2014-07-23       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.